There is a little known company that is changing warfare

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t

Yvonne Tran Biography and Net Worth

EVP of Schrödinger

Yvonne Tran, Executive Vice President and Chief Legal Officer, joined Schrödinger in 2010. Prior to joining Schrödinger, she served as Senior Corporate Counsel at Oracle America, Inc. and as Deputy General Counsel at DoubleClick Inc. As an in-house lawyer, she negotiated complex intellectual property and commercial transactions and provided legal support on M&A matters and intellectual property litigations. Yvonne worked at various law firms in New York immediately after law school, and her practice included intellectual property counseling and litigation. She has extensive experience in the software and technology services industries. Yvonne graduated from Yale in 1992 with a B.A. in Molecular Biophysics & Biochemistry and from the University of Virginia School of Law in 1995.

What is Yvonne Tran's net worth?: The estimated net worth of Yvonne Tran is at least $221,794.02 as of February 12th, 2024. Ms. Tran owns 11,963 shares of Schrödinger stock worth more than $221,794 as of November 17th. This net worth approximation does not reflect any other assets that Ms. Tran may own. Learn More about Yvonne Tran's net worth.
How do I contact Yvonne Tran?: The corporate mailing address for Ms. Tran and other Schrödinger executives is 120 WEST 45TH STREET 17TH FLOOR, NEW YORK NY, 10036. Schrödinger can also be reached via phone at 212-295-5800 and via email at [email protected]. Learn More on Yvonne Tran's contact information.
Has Yvonne Tran been buying or selling shares of Schrödinger?: Yvonne Tran has not been actively trading shares of Schrödinger over the course of the past ninety days. Most recently, Yvonne Tran sold 758 shares of the business's stock in a transaction on Monday, February 12th. The shares were sold at an average price of $28.29, for a transaction totalling $21,443.82. Following the completion of the sale, the executive vice president now directly owns 11,963 shares of the company's stock, valued at $338,433.27. Learn More on Yvonne Tran's trading history.
Who are Schrödinger's active insiders?: Schrödinger's insider roster includes Robert Abel (Insider), Karen Akinsanya (Insider), Rosana Kapeller-Libermann (Director), Joel Lebowitz (CFO), David Shaw (Major Shareholder), Yvonne Tran (EVP), and Jorg Weiser (Director). Learn More on Schrödinger's active insiders.
Are insiders buying or selling shares of Schrödinger?: During the last twelve months, insiders at the sold shares 5 times. They sold a total of 5,182 shares worth more than $129,616.27. The most recent insider tranaction occured on October, 15th when insider Margaret Dugan sold 1,531 shares worth more than $27,221.18. Insiders at Schrödinger own 8.6% of the company. Learn More about insider trades at Schrödinger.
Information on this page was last updated on 10/15/2024.

Yvonne Tran Insider Trading History at Schrödinger

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/12/2024	Sell	758	$28.29	$21,443.82	11,963
6/30/2023	Sell	12,040	$50.00	$602,000.00	12,721
5/23/2023	Sell	7,960	$40.01	$318,479.60	12,721
4/1/2021	Sell	13,377	$79.58	$1,064,541.66	30,508
2/22/2021	Sell	10,000	$113.66	$1,136,600.00	26,731

Yvonne Tran Buying and Selling Activity at Schrödinger

Schrödinger Company Overview

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Today's Range

Now: $18.54

$18.46

$20.46

50 Day Range

MA: $18.72

$16.98

$22.25

2 Week Range

Now: $18.54

$16.67

$38.00

Volume

1,221,118 shs

Average Volume

876,651 shs

Market Capitalization

$1.35 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.5